Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2026-01-06 @ 7:10 PM
Study NCT ID:
NCT02175966
Status:
COMPLETED
Last Update Posted:
2020-08-11
First Post:
2014-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2015-01-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12-17
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-25
First Submit QC Date:
None
Study First Post Date:
2014-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-22
Results First Submit QC Date:
None
Results First Post Date:
2019-05-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-03-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-08-07
Last Update Post Date:
2020-08-11
Last Update Post Date Type:
ACTUAL